Mango Sciences is a UAE and US based HealthTech company, building the world’s largest non-Caucasian oncology dataset while transforming access to precision medicine in emerging markets. Its AI-powered platform, Querent, enables real-world data applications across value-based financing, clinical trials, and drug development.

We first invested in Mango Sciences, drawn by the uniqueness of the opportunity, the defensibility of the model, and the technical strength of the founding team. As pharma increasingly shifts toward data-driven, globally inclusive approaches, Mango Sciences is uniquely positioned to unlock innovation and value across the healthcare ecosystem. Through its proprietary dataset of 2.6 million patient lives and strategic partnerships with major pharmaceutical companies, the team is driving impact across clinical trial recruitment, real-world evidence and analytics, and value-based financing to expand access to cancer care.

Moreover, the founders continue to impress us with their balance of conviction and humility in leadership, demonstrating a natural adaptability to changing market conditions and thoughtful company-building as Mango Sciences builds its highly specialized team.

Visit Mango Sciences’ Website